期刊
BIOLOGICAL RESEARCH
卷 49, 期 -, 页码 -出版社
SOC BIOLGIA CHILE
DOI: 10.1186/s40659-016-0093-4
关键词
Dyskinesia; Levodopa liposomes; ERK1/2; DARPP-32; FosB/Delta FosB
类别
资金
- National Natural Science Foundation of China [30700881, 81171193]
Background: Chitosan, the N-deacetylated derivative of chitin, is a cationic polyelectrolyte due to the presence of amino groups, one of the few occurring in nature. The use of chitosan in protein and drug delivery systems is being actively researched and reported in the literature. Results: In this study, we used chitosan-coated levodopa liposomes to investigate the behavioral character and the expression of phosphorylated extracellular signal-regulated kinase (ERK1/2), dopamine-and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) and FosB/Delta FosB in striatum of rat model of levodopa-induced dyskinesia (LID). We found that scores of abnormal involuntary movement (AIM) decreased significantly in liposome group (P < 0.05), compared with levodopa group. Levels of phospho-ERK1/2, phospho-Thr34 DARPP-32 and FosB/Delta FosB in striatum decreased significantly in liposome group lesion side compared with levodopa group (P < 0.05). However, both of two groups above have significantly differences compared with the control group (P < 0.05). Conclusion: Chitosan-coated levodopa liposomes may be useful in reducing dyskinesias inducing for Parkinson disease. The mechanism might be involved the pathway of signaling molecular phospho-ERK1/2, phospho-Thr34 DARPP-32 and Delta FosB in striatum.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据